海思科(002653.SZ):員工持股平台成都海賽特擬向成都賽拉諾增資2065萬元
格隆匯 7 月 16日丨海思科(002653.SZ)公佈,公司控股子公司成都賽拉諾醫療科技有限公司(“成都賽拉諾”)為充分調動核心人員工作積極性,進一步保障核心人員穩定、積極、長期投入工作,加速推進在研產品研發進程擬實施股權激勵,由員工持股平台成都海賽特企業管理諮詢合夥企業(有限合夥)(“成都海賽特”)對成都賽拉諾進行增資。成都海賽特將出資2065萬元人民幣,其中1750萬元計入註冊資本。成都賽拉諾現有註冊資本2.62億元人民幣,增資完成後,註冊資本將變為2.795億元人民幣,溢價部分計入資本公積。
成都賽拉諾致力於開發國際先進水平的介入式心臟瓣膜系統。
此次交易目的為實施成都賽拉諾員工股權激勵,有利於激勵成都賽拉諾核心人員工作積極性,為公司及成都賽拉諾創造更大的價值。公司實施此次控股子公司員工股權激勵將計提因股權激勵產生的股份支付費用,可能會對公司的經營業績有一定影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.